Ho J, Cheng E, Wong C, St-Germain J, Dunham W, Raught B
EMBO Rep. 2025; 26(5):1290-1314.
PMID: 39870965
PMC: 11894219.
DOI: 10.1038/s44319-025-00374-z.
Zhang X, Zhu T, Li X, Zhao H, Lin S, Huang J
Proc Natl Acad Sci U S A. 2024; 121(35):e2321204121.
PMID: 39172782
PMC: 11363268.
DOI: 10.1073/pnas.2321204121.
Zhang L, Hsu J, Braekeleer E, Chen C, Patel T, Martell A
Elife. 2024; 12.
PMID: 38896450
PMC: 11186636.
DOI: 10.7554/eLife.91611.
Wang X, Bai F, Liu X, Peng B, Xu X, Zhang H
BMC Biol. 2024; 22(1):85.
PMID: 38627785
PMC: 11020915.
DOI: 10.1186/s12915-024-01881-6.
Li Z, You L, Hermann A, Bier E
Nat Commun. 2024; 15(1):2629.
PMID: 38521791
PMC: 10960810.
DOI: 10.1038/s41467-024-46479-2.
PTEN-mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells.
He J, Huang C, Guo Y, Deng R, Li L, Chen R
Mol Oncol. 2023; 18(3):580-605.
PMID: 38060346
PMC: 10920079.
DOI: 10.1002/1878-0261.13563.
R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription-Replication Conflicts.
Liu Z, Sinha S, Bannister M, Song A, Arriaga-Gomez E, McKeeken A
Cancer Res. 2023; 84(4):577-597.
PMID: 37967363
PMC: 10922727.
DOI: 10.1158/0008-5472.CAN-23-3239.
SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation.
Chen C, Zhang L, Dutta R, Niroula A, Miller P, Gibson C
Cell Stem Cell. 2023; 30(11):1503-1519.e8.
PMID: 37863054
PMC: 10841682.
DOI: 10.1016/j.stem.2023.09.011.
is a synthetic lethal target in -mutant leukemia cells.
Zhang L, Hsu J, Braekeleer E, Chen C, Patel T, Martell A
bioRxiv. 2023; .
PMID: 37693622
PMC: 10491179.
DOI: 10.1101/2023.08.31.555634.
SOSSB1 and SOSSB2 mutually regulate protein stability through competitive binding of SOSSA.
Zhang Q, Hao R, Chen H, Zhou G
Cell Death Discov. 2023; 9(1):319.
PMID: 37640700
PMC: 10462637.
DOI: 10.1038/s41420-023-01619-3.
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer.
Schultz C, Zhang Y, Elmeskini R, Zimmermann A, Fu H, Murai Y
EMBO Mol Med. 2023; 15(8):e17313.
PMID: 37491889
PMC: 10405061.
DOI: 10.15252/emmm.202217313.
LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer.
Dey G, Bharti R, Braley C, Alluri R, Esakov E, Crean-Tate K
J Ovarian Res. 2023; 16(1):122.
PMID: 37370140
PMC: 10294509.
DOI: 10.1186/s13048-023-01194-2.
BMAL1 collaborates with CLOCK to directly promote DNA double-strand break repair and tumor chemoresistance.
Zhang C, Chen L, Sun L, Jin H, Ren K, Liu S
Oncogene. 2023; 42(13):967-979.
PMID: 36725890
PMC: 10038804.
DOI: 10.1038/s41388-023-02603-y.
APOBEC3G protects the genome of human cultured cells and mice from radiation-induced damage.
Britan-Rosich Y, Ma J, Kotler E, Hassan F, Botvinnik A, Smith Y
FEBS J. 2022; 290(7):1822-1839.
PMID: 36325681
PMC: 10079569.
DOI: 10.1111/febs.16673.
The histone modification reader ZCWPW1 promotes double-strand break repair by regulating cross-talk of histone modifications and chromatin accessibility at meiotic hotspots.
Yuan S, Huang T, Bao Z, Wang S, Wu X, Liu J
Genome Biol. 2022; 23(1):187.
PMID: 36068616
PMC: 9446545.
DOI: 10.1186/s13059-022-02758-z.
ARL2 is required for homologous recombination repair and colon cancer stem cell survival.
Lee H, Choi S, Ha S, Yoon S, Kim W
FEBS Open Bio. 2022; 12(8):1523-1533.
PMID: 35567502
PMC: 9340879.
DOI: 10.1002/2211-5463.13438.
An Expanding Toolkit for Heterochromatin Repair Studies.
Rawal C, Butova N, Mitra A, Chiolo I
Genes (Basel). 2022; 13(3).
PMID: 35328082
PMC: 8955653.
DOI: 10.3390/genes13030529.
Quinacrine Induces Nucleolar Stress in Treatment-Refractory Ovarian Cancer Cell Lines.
Oien D, Ray U, Pathoulas C, Jin L, Thirusangu P, Jung D
Cancers (Basel). 2021; 13(18).
PMID: 34572872
PMC: 8466834.
DOI: 10.3390/cancers13184645.
Non-canonical function of DGCR8 in DNA double-strand break repair signaling and tumor radioresistance.
Hang Q, Zeng L, Wang L, Nie L, Yao F, Teng H
Nat Commun. 2021; 12(1):4033.
PMID: 34188037
PMC: 8242032.
DOI: 10.1038/s41467-021-24298-z.
The PTEN and ATM axis controls the G1/S cell cycle checkpoint and tumorigenesis in HER2-positive breast cancer.
Bassi C, Fortin J, Snow B, Wakeham A, Ho J, Haight J
Cell Death Differ. 2021; 28(11):3036-3051.
PMID: 34059798
PMC: 8564521.
DOI: 10.1038/s41418-021-00799-8.